|
|
Article: LifeSpan BioSciences Enters into Agreement with Major Pharmaceutical Company for Expanded DrugTarget Localization Database.
- Article from:
- Business Wire
- Article date:
- August 23, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEATTLE -- LifeSpan BioSciences, Inc., a leading proteomics company specializing in molecular pathology, today announced an agreement, valued at $2 million, with an undisclosed major international pharmaceutical company for a subscription to LifeSpan's DrugTarget Database(TM). This subscription agreement marks the 50th subscriber to LifeSpan's DrugTarget data.
LifeSpan's DrugTarget Database is the industry's largest resource for proprietary human protein localization data for drug targets in eight important gene families, including G protein-coupled receptors (GPCRs), nuclear hormone receptors (NHRs), kinases, ion channels, phosphatases, proteases, ...